Nicholas Lorusso
Stock Analyst at TD Cowen
(3.72)
# 2,060
Out of 5,014 analysts
19
Total ratings
54.5%
Success rate
28.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicholas Lorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Reiterated: Buy | $10 → $16 | $14.82 | +7.96% | 2 | Sep 29, 2026 | |
| KROS Keros Therapeutics | Rated: Hold | n/a | $11.39 | - | 4 | Aug 21, 2026 | |
| IMTX Immatics | Reiterated: Buy | n/a | $8.78 | - | 5 | Aug 18, 2026 | |
| ARVN Arvinas | Reiterated: Hold | n/a | $7.74 | - | 1 | Aug 4, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Reiterated: Buy | $65 → $95 | $74.61 | +27.33% | 7 | Jul 28, 2026 |
Iovance Biotherapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $10 → $16
Current: $14.82
Upside: +7.96%
Keros Therapeutics
Aug 21, 2026
Rated: Hold
Price Target: n/a
Current: $11.39
Upside: -
Immatics
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.78
Upside: -
Arvinas
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.74
Upside: -
Kiniksa Pharmaceuticals International,
Jul 28, 2026
Reiterated: Buy
Price Target: $65 → $95
Current: $74.61
Upside: +27.33%